The regulation role and diagnostic value of fibrinogen-like protein 1 revealed by pan-cancer analysis

Yi, Wang; Qiao, Tingting; Yang, Ziyu; Hu, Lei; Sun, Mingming; Fan, Hengwei; Xu, Yanping; Lv, Zhongwei

doi:10.1016/j.mtbio.2022.100470

Cited by 5 publications

(1 citation statement)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The pan-cancer analysis is a comprehensive and systematic approach to investigating and assessing the function and mechanism of a specific gene in tumorigenesis. Using the TCGA database, several genes were identified that may have a role in human cancers, such as FGL1 [30], CARM1 [31], CBX [32], LCK [33], and MNX1 [34]. In the present study, we conducted a systematic analysis of SKP2 expression across a variety of tumor forms, and the results revealed that practically most tumor types overexpressed SKP2 ).…”

Section: Discussionmentioning

confidence: 74%

Pan-Cancer Analysis of the Expression and Prognostic Value of S-Phase Kinase-Associated Protein 2

Nguyen

Hoang

Bui

2023

Open Access Maced J Med Sci

View full text Add to dashboard Cite

BACKGROUND: S-Phase Kinase-Associated Protein 2 (SKP2) is essential in modulating metabolism processes, cell proliferation, and carcinogenesis DUE to its capacity to ubiquitinate and degrade various tumor-suppressive substrates. However, the actual biological and mechanism significance of SKP2 in the development of tumors and as a possible therapeutic target remains to be completely understood. AIM: This study aimed to explore the potential roles of the SKP2 gene in the oncologic pathogenesis of various cancers through an in-depth pan-cancer analysis including gene expression assessment, survival analysis, genetic alteration, and enrichment analysis. METHODS: Public databases including the Cancer Genome Atlas database, Genotype-Tissue Expression Project database, cBioPortal database, Gene Expression Profiling Interactive Analysis 2 database, Tumor Immune Estimation Resource version 2.0 database, and STRING database were used to detect the SKP2 expression, molecular mechanism, and its association with the prognosis across pan-cancer. RESULTS: SKP2 was significantly highly expressed in most types of cancers and was substantially correlated to the poor survival of patients with specific cancers based on the log-rank test. SKP2 had the highest frequency of alteration in lung cancer and amplification was the most common genetic alteration type. Finally, SKP2-related genes were identified and enrichment analyses were conducted. CONCLUSION: This study presented the first demonstration of the pan-cancer landscape of abnormal SKP2 expression, it could potentially serve as a predictive indicator and prospective therapeutic target.

show abstract